Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1354127 | 0.93 | MAPK14 (0.69) | MAPK14MAPTKDM4ECYP1A2CYP3A4 | |
| SCHEMBL5254380 | 0.89 | MAPK14 (1.00) | MAPK14PTGS1PTGS2 | |
| SCHEMBL8274926 | 0.84 | MAPK14 (0.64) | MAPK14MAPTPTGS1PTGS2 | |
| SCHEMBL3834215 | 0.82 | MAPK14 (0.57) | MAPK14MAPTKDM4ECYP1A2CYP3A4 | |
| SCHEMBL1681771 | 0.76 | PTGS2 (0.65) | MAPK14PTGS1PTGS2 | |
| SCHEMBL1356427 | 0.76 | MAPK14 (0.50) | MAPK14MAPTKDM4ECYP1A2CYP3A4 | |
| SCHEMBL9812737 | 0.76 | MAPK14 (0.50) | MAPK14MAPTKDM4ECYP1A2CYP3A4 | |
| SCHEMBL1425244 | 0.76 | CYP2A6 (0.62) | MAPK14MAPTKDM4ECYP1A2CYP3A4 | |
| SCHEMBL23212775 | 0.75 | MAPK14 (0.50) | MAPK14MAPTKDM4ELMNAPOLB | |
| SCHEMBL2782853 | 0.74 | PTGS2 (0.68) | MAPK14PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118943354-A | Positive electrode material, preparation method thereof, positive electrode plate, battery and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118943354-A | Positive electrode material, preparation method thereof, positive electrode plate, battery and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-11-12 | — | — | CN | disclosed |
| US-20220098217-A1 | COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-31 | — | — | US | disclosed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | disclosed |
| EP-0668277-B1 | Bipyridyl-oligothiophene derivatives as electron-conducting materials | VALTION TEKNILLINEN (FI) | 1998-11-04 | — | — | EP | disclosed |
| US-5556524-A | DIAGNOSTICS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1996-09-17 | — | — | US | disclosed |
| EP-0668277-A1 | Bipyridyl-oligothiophene derivatives as electron-conducting materials | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1995-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | OCIAD1, NLRP3, OCIAD2 | MAPK14 2491/4885MAPT 71/4885KDM4E 4019/4885 |
| US-20220098217-A1 | COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | AOX1, OXER1, OR51E2 | MAPK14 773/4885MAPT 2875/4885KDM4E 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.